Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes von MADAMANCHI, N. R., HAKIM, Z. S., RUNGE, M. S.

Volltext

Construction and characterization of a recombinant plasminogen activator composed of an anti‐fibrin single‐chain antibody and low‐molecular‐weight urokinase von Hagemeyer, C. E., Tomic, I., Weirich, U., Graeber, J., Nordt, T., Runge, M. S., Bode, C., Peter, K.

Volltext

Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor von Zhong, C, Hayzer, D J, Corson, M A, Runge, M S

Volltext

Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells von Rao, G.N., Runge, M.S., Alexander, R.W.

Volltext

The no‐reflow phenomenon in coronary arteries von Kelly, R.V., Cohen, M.G., Runge, M.S., Stouffer, G. A.

Volltext

Role of Aldose reductase in growth factor-induced proliferation of vascular smooth muscle cells von Ruef, J., Hu, Z., Bode, C., Runge, M.S., Bhatnagar, A.

Volltext

Elimination of a major inhibitor epitope in factor VIII von LUBIN, I. M, HEALEY, J. F, SCANDELLA, D, RUNGE, M. S, LOLLAR, P

Volltext

“Low-risk” chest pain patients may be at high risk for cardiac events: prospective use of troponin T for risk stratification von Parmar, R.J., Abreo, G., Uretsky, B.F., Runge, M.S., deFilippi, C.R.

Volltext

Involvement of 4-hydroxynonenal in vascular smooth muscle cell signaling and atherosclerosis von Ruel, J., Hu, Z., Boda, C., Runge, M.S.

Volltext

Hydrogen peroxide activation of cytosolic phospholipase A 2 in vascular smooth muscle cells von Rao, G.N., Runge, M.S., Alexander, R.W.

Volltext

Prospective randomized evaluation of immediate exercise treadmill testing or angiography for low risk patients observed in a chest pain unit: long-term follow-up von Abreo, G., Parmar, R.J., Potter, M., Runge, M.S., Uretsky, B.F., deFilippi, C.R.

Volltext

Construction and Expression of a Recombinant Antibody-Targeted Plasminogen Activator von Schnee, Janet M., Runge, Marschall S., Matsueda, Gary R., Hudson, Norman W., Seidman, Jonathan G., Haber, Edgar, Quertermous, Thomas

Volltext

Characterization of an antibody-urokinase conjugate. A plasminogen activator targeted to fibrin von Bode, C, Runge, M S, Newell, J B, Matsueda, G R, Haber, E

Volltext

The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator von LUBIN, I. M, CABAN, R, RUNGE, M. S

Volltext

Thrombolytic agents — an updated overview von Gulba, D.C., Bode, C., Runge, M.S., Huber, K.

Volltext

Effects of fluid shear stress on atherogenesis and hemostasis von Ruef, J., Bode, C., Runge, M.S.

Volltext

New developments in thrombolytic therapy von Bode, C., Peter, K., Nordt, T., Kohler, B., Moser, M., Ruef, J., Runge, M.S.

Volltext

Targeting of thrombolytic and antithrombotic agents von Bode, C., Nordt, T.K., Peter, K., Ruef, J., Runge, M.S., Kübler, W.

Volltext

Cyclic nucleotide phosphodiesterase activity in 10-nm filaments and microtubule preparations from bovine brain von Runge, Marschall S., Hewgley, Paula B., Puett, David, Williams, Robley C.

Volltext

Reteplase (r-PA): a novel recombinant plasminogen activator von Bode, C., Kohler, B., Smalling, R.W., Runge, M.S.

Volltext